Combining Growth Hormone-Releasing Hormone Antagonist With Luteinizing Hormone-Releasing Hormone Antagonist Greatly Augments Benign Prostatic Hyperplasia Shrinkage-Reference-Cited by-同舟云学术

Combining Growth Hormone-Releasing Hormone Antagonist With Luteinizing Hormone-Releasing Hormone Antagonist Greatly Augments Benign Prostatic Hyperplasia Shrinkage

Published:2012-04 Issue:4 Volume:187 Page:1498-1504
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Rick Ferenc G.¹²,Szalontay Luca¹,Schally Andrew V.³,Block Norman L.³,Nadji Mehrdad²,Szepeshazi Karoly¹,Vidaurre Irving¹,Zarandi Marta¹²,Kovacs Magdolna¹²⁴,Rekasi Zoltan⁴

Affiliation:

1. Veterans Affairs Medical Center and South Florida Veterans Affairs Foundation for Research and Education, Miami, Florida

2. Department of Pathology, Miller School of Medicine, University of Miami, Miami, Florida

3. Divisions of Hematology/Oncology and Endocrinology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida

4. Department of Anatomy, School of Medicine, University of Pecs, Pecs, Hungary

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Benign prostatic hyperplasia: an overview;Roehrborn;Rev Urol,2005

2. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia;Rick;Proc Natl Acad Sci U S A,2011